Inhibrx Biosciences, Inc.
INBX • NASDAQ
Inhibrx Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark Paul Lappe, with a market cap of $852.9M.
Market Cap$852.9M
Employees172.0
CEOMark Paul Lappe
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Inhibrx Biosciences, Inc. FAQ
Common questions about Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Inhibrx Biosciences, Inc. has approximately 172 employees.